Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Remmers

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Biochemistry|October 21, 1999
Interdomain interactions regulate GDP release from heterotrimeric G proteinsA E Remmers, C Engel, M Liu, et al.
Biochemistry|March 9, 1993
Synthesis and characterization of fluorescently labeled bovine brain G protein subunitsG Kwon, A E Remmers, S Datta, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacyA E Remmers, M J Clark, X Y Liu, et al.
Clinical Pharmacology and Therapeutics|September 21, 2007
Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic painK G Kowalski, S Olson, A E Remmers, et al.
Journal of Neurochemistry|July 1, 1999
Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacyP J Emmerson, M J Clark, F Medzihradsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1997
Novel form of crosstalk between G protein and tyrosine kinase pathwaysM Diversé-Pierluissi, A E Remmers, R R Neubig, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptorA E Remmers, M J Clark, A Mansour, et al.
British Journal of Clinical Pharmacology|July 11, 2006
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifeneD Ouellet, C Bramson, D Roman, et al.
The Journal of Biological Chemistry|November 4, 1994
Binding of an alpha 2 adrenergic receptor third intracellular loop peptide to G beta and the amino terminus of G alphaJ M Taylor, G G Jacob-Mosier, R G Lawton, et al.
European Journal of Pharmacology|May 24, 2000
Activation of G protein by opioid receptors: role of receptor number and G-protein concentrationA E Remmers, M J Clark, A Alt, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biochemistry|October 21, 1999
Interdomain interactions regulate GDP release from heterotrimeric G proteinsA E Remmers, C Engel, M Liu, et al.
Biochemistry|March 9, 1993
Synthesis and characterization of fluorescently labeled bovine brain G protein subunitsG Kwon, A E Remmers, S Datta, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacyA E Remmers, M J Clark, X Y Liu, et al.
Clinical Pharmacology and Therapeutics|September 21, 2007
Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic painK G Kowalski, S Olson, A E Remmers, et al.
Journal of Neurochemistry|July 1, 1999
Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacyP J Emmerson, M J Clark, F Medzihradsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1997
Novel form of crosstalk between G protein and tyrosine kinase pathwaysM Diversé-Pierluissi, A E Remmers, R R Neubig, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptorA E Remmers, M J Clark, A Mansour, et al.
British Journal of Clinical Pharmacology|July 11, 2006
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifeneD Ouellet, C Bramson, D Roman, et al.
The Journal of Biological Chemistry|November 4, 1994
Binding of an alpha 2 adrenergic receptor third intracellular loop peptide to G beta and the amino terminus of G alphaJ M Taylor, G G Jacob-Mosier, R G Lawton, et al.
European Journal of Pharmacology|May 24, 2000
Activation of G protein by opioid receptors: role of receptor number and G-protein concentrationA E Remmers, M J Clark, A Alt, et al.
Pageof 3